| Address:
|
750 BATTERY STREET
SUITE 330 |
| City: |
SAN FRANCISCO |
|
State: |
CA |
|
Zip Code: |
94111 |
| Telephone: |
206-286-2501 |
|
Description of Business
|
Primary SIC Code:
2834 |
| (As filed with the SEC)
|
|
|
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
development and commercialization of cancer therapeutics. Our lead product
candidate is picoplatin, a new generation platinum-based cancer therapy that has
the potential to become a platform product for use in different formulations, as
a single agent or in combination with other anti-cancer agents, to treat
multiple cancer indications. Picoplatin is a chemotherapeutic designed to treat
solid tumors that are resistant to existing platinum-based cancer
therapies. Clinical studies in over 1,100 patients to date suggest that
picoplatin has an improved safety profile relative to existing platinum-based
cancer therapies. We have completed a pivotal Phase 3 SPEAR (Study of Picoplatin
Efficacy After Relapse) trial of picoplatin in the second-line treatment of
patients with small cell lung cancer. ... More ... |
| Date |
12-mos
Rolling EPS |
Dividend |
P/E
Ratio |
| There's no share overview data. |
Key Financial Ratios and Statistics |
FYE:
12/31 |
| Profitability |
2010 |
Leverage |
2010 |
| Net Inc/Comm Equity | -0.07 | Total Liab/Total Assets | 0.27 | | Net Inc/Total Assets | -2.58 | Total Liab/Inv Cap | 0.32 | | Net Inc/Inv Cap | -3.00 | Total Liab/Comm Equity | 0.01 | | Pretax Inc/Net Sales | NA | Interest Coverage Ratio | -12.60 | | Net Inc/Net Sales | NA | Curr Debt/Equity | NA | | Cash Flow/Net Sales | NA | LTD/Equity | 0.19 | | SG&A/NetSales | NA | Total Debt/Equity | 0.19 |
| Asset Utilization
|
|
Liquidity |
|
| Net Receivables Turnover | NA | Quick Ratio | 3.23 | | Inventory Turnover | NA | Current Ratio | 3.23 | | Inventory Day Sales | NA | Net Rec/Curr Assets | NA | | Net Sales/Work Cap | NA | Inv/Curr Assets | NA | | Net Sales/PP&E | NA | | |
Income Statement (Millions) |
| |
9/30/2011
|
6/30/2011
|
3/31/2011
|
12/31/2010
|
|
Total Revenues(Net Sales)
|
NA
|
NA
|
NA
|
NA
|
|
Cost of Goods Sold
|
NA
|
NA
|
NA
|
NA
|
|
Selling & Admin Exps
|
3.46
|
3.40
|
2.90
|
4.61
|
|
Operating Income
|
-3.75
|
-3.84
|
-3.23
|
-4.72
|
|
Interest Exp
|
0.02
|
0.02
|
0.02
|
0.47
|
|
Pretax Income
|
-3.77
|
-3.86
|
-3.25
|
-5.17
|
|
Other Income
|
0.00
|
0.00
|
0.01
|
0.01
|
|
Net Income Bef Extraordinary ...
|
NA
|
NA
|
NA
|
NA
|
|
Net Income
|
-3.77
|
-3.86
|
-3.25
|
-5.17
|
|
Assets
|
9/30/2011
|
6/30/2011
|
3/31/2011
|
12/31/2010
|
|
Cash & Short Term Investments
|
1.98
|
3.85
|
5.63
|
4.49
|
|
Receivables - Total
|
NA
|
NA
|
NA
|
NA
|
|
Inventories - Total
|
NA
|
NA
|
NA
|
NA
|
|
Total Current Assets
|
2.25
|
4.19
|
6.11
|
5.22
|
|
Net Property, Plant & Equipment
|
0.02
|
0.03
|
0.04
|
0.05
|
|
Total Assets
|
7.74
|
9.99
|
12.22
|
11.64
|
|
Liabilities
|
|
|
|
|
|
Accounts Payable
|
2.98
|
2.09
|
1.28
|
1.62
|
|
Debt in Current Liabilities
|
NA
|
NA
|
NA
|
0.00
|
|
Total Current Liabilities
|
2.98
|
2.09
|
1.28
|
1.62
|
|
Long-Term Debt
|
1.64
|
1.62
|
1.60
|
1.57
|
|
Total Liabilities
|
4.62
|
3.71
|
2.88
|
3.19
|
|
Stockholder's Equity
|
|
|
|
|
|
Minority Interest
|
NA
|
NA
|
NA
|
NA
|
|
Preferred Stock
|
0.00
|
0.00
|
0.00
|
0.00
|
|
Common Stock
|
1.20
|
1.20
|
1.18
|
0.97
|
|
Retained Earnings
|
-449.96
|
-446.14
|
-442.24
|
-438.94
|
|
Treasury Stock
|
NA
|
NA
|
NA
|
NA
|
|
Total Stockholders' Equity
|
3.12
|
6.28
|
9.34
|
8.45
|
|
Total Liabilities and Stockholders' Equity
|
7.74
|
9.99
|
12.22
|
11.64
|
Cash Flow Summary (Millions) |
|
Categories
|
9/30/2011
|
6/30/2011
|
3/31/2011
|
12/31/2010
|
|
Net Cash Provided by Operating Activities
|
-1.71
|
-1.68
|
-2.02
|
-5.05
|
|
Net Cash Provided by Investing Activities
|
0.00
|
-0.00
|
3.03
|
9.21
|
|
Net Cash Provided by Financing Activities
|
0.00
|
-0.10
|
3.18
|
-13.90
|
Annual Summary Data (Millions) |
| Year |
Sales |
Net
Income |
EPS |
| 12/2006 | 0.00 | -23.29 | -- | | 12/2007 | 0.00 | -32.78 | -- | | 12/2008 | 0.00 | -48.56 | -- | | 12/2009 | 0.00 | -45.72 | -- | | 12/2010 | 0.00 | -30.05 | -- | | Growth Rates | NaN | -- | -- |
| Type |
Date(Q,M) |
No.
Owners |
Shares
Held (000s) |
%
Own |
| There's no stock ownership data. |
|
Report Date :
11/28/2011
 Copyright
2011, EDGAR Online, Inc. All
rights reserved. Replication or redistribution of EDGAR Online, Inc. content is
expressly prohibited without the prior written consent of EDGAR Online, Inc.
EDGAR Online, Inc. shall not be liable for any errors or delays in the content,
or for any actions taken in reliance thereon.
|
|
|